表紙
市場調查報告書

生物反應器的全球市場:2019年∼2023年

Global Bioreactors Market 2019-2023

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 781916
出版日期 內容資訊 英文 117 Pages
訂單完成後即時交付
價格
Back to Top
生物反應器的全球市場:2019年∼2023年 Global Bioreactors Market 2019-2023
出版日期: 2019年01月17日內容資訊: 英文 117 Pages
簡介

拋棄式生物反應器的需求,由於其各種特性,在全球生物反應器市場顯著增加。拋棄式生物反應器比不袗生物反應器更易於使用,可以方便地設置用於連續處理。補料分批製造過程中使用的拋棄式生物反應器易於轉換以適應連續處理操作的要求。此外,拋棄式生物反應器可以降低維護成本,因其不需要與傳統不袗生物反應器相同的公用設施和管道基礎設施,這也減少了潔淨室所需的空間。因此,預計拋棄式生物反應器的需求成長將推動生物反應器的長期市場銷售。Technavio的分析師預測,全球生物反應器市場至2023年,將以約7%的年複合成長率成長。

本報告提供全球生物反應器市場相關調查分析,市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 報告的範圍

  • 簡介1
  • 簡介2
  • 美金的貨幣換算比率

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 市場區隔分析

第4章 市場規模

  • 市場定義
  • 市場規模(2018年)
  • 市場規模及預測(2018年∼2023年)

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情況

第6章 市場區隔:各終端用戶

  • 市場區隔:各終端用戶
  • 各終端用戶比較:市場規模及預測(2018年∼2023年)
  • 生物醫藥品企業
  • 研究所
  • 受託研究機構
  • 市場機會:各終端用戶

第7章 客戶形勢

第8章 地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模及預測(2018年∼2023年)
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 主要國家
  • 市場機會

第9章 成長要素與課題

  • 市場成長要素
  • 市場課題

第10章 市場趨勢

第11章 業者情勢

  • 概要
  • 創造性破壞狀況

第12章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • Danaher
  • GE Healthcare
  • Merck KGaA
  • Sartorius
  • Thermo Fisher Scientific

第13章 附錄

目錄
Product Code: IRTNTR30694

About this market

The demand for single-use bioreactors has increased significantly in the global bioreactors market owing to their various attributes. Single-use bioreactors are simpler to use than stainless steel bioreactors because of the ease with which they can be set up for continuous processing. A single-use bioreactor that has been used in a fed-batch manufacturing process can be easily converted to fit the requirements of a continuous processing operation. Additionally, a single-use bioreactor enables a reduction in the maintenance costs as it does not require the same utility and piping infrastructure as a traditional stainless-steel bioreactor, which also reduces the space required within the cleanroom. Hence, the growing demand for single-use bioreactors is expected to boost the market sales of bioreactors in the long-run. Technavio's analysts have predicted that the bioreactors market will register a CAGR of almost 7% by 2023.

Market Overview

Increased availability of accessory products

Vendors in the bioreactors market are offering accessory products with improved features and with specific manufacturing standards to make a mark in the market. The accessory products allow market vendors to retain their existing consumers and also attract new customers. Such product offerings help in attracting prospective consumers, thus leading to increased sales and high-volume production among vendors, which will support the growth of the global bioreactors market during the forecast period.

Ethical issues related to bioprocessing of stem cells for regenerative medicine

Regenerative medicine aims at restoring the structure and function of damaged organs and tissues using stem cells. Thus, amid the growing ethical concerns worldwide, animal testing must be regulated by government agencies to minimize the use of animals for research in regenerative medicine. Therefore, the existence of ethical issues pertaining to the bioprocessing of tissue samples may hamper ongoing research in stem cells, which might reduce the demand for bioreactors, and thus have a negative impact on the growth of the global bioreactors market during the forecast period.

For the detailed list of factors that will drive and challenge the growth of the bioreactors market during the 2019-2023, view our report.view our report.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY END-USER

  • Market segmentation by end-user
  • Comparison by end-user
  • Biopharmaceutical companies - Market size and forecast 2018-2023
  • Research institutes - Market size and forecast 2018-2023
  • Contract research organizations - Market size and forecast 2018-2023
  • Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 10: MARKET TRENDS

PART 11: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 12: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Danaher
  • GE Healthcare
  • Merck KGaA
  • Sartorius
  • Thermo Fisher Scientific

PART 13: APPENDIX

List of Exhibits

  • Exhibit 01: Global biotechnology market
  • Exhibit 02: Segments of global biotechnology market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2018
  • Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 09: Five forces analysis 2018
  • Exhibit 10: Five forces analysis 2023
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2018
  • Exhibit 17: End-user - Market share 2018-2023 (%)
  • Exhibit 18: Comparison by end-user
  • Exhibit 19: Biopharmaceutical companies - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 20: Biopharmaceutical companies - Year-over-year growth 2019-2023 (%)
  • Exhibit 21: Research institutes - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 22: Research institutes - Year-over-year growth 2019-2023 (%)
  • Exhibit 23: Contract research organizations - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 24: Contract research organizations - Year-over-year growth 2019-2023 (%)
  • Exhibit 25: Market opportunity by end-user
  • Exhibit 26: Customer landscape
  • Exhibit 27: Market share by geography 2018-2023 (%)
  • Exhibit 28: Geographic comparison
  • Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 30: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 32: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 34: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 36: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 37: Key leading countries
  • Exhibit 38: Market opportunity
  • Exhibit 39: Impact of drivers and challenges
  • Exhibit 40: Vendor landscape
  • Exhibit 41: Landscape disruption
  • Exhibit 42: Vendors covered
  • Exhibit 43: Vendor classification
  • Exhibit 44: Market positioning of vendors
  • Exhibit 45: Danaher - Vendor overview
  • Exhibit 46: Danaher - Business segments
  • Exhibit 47: Danaher - Organizational developments
  • Exhibit 48: Danaher - Geographic focus
  • Exhibit 49: Danaher - Segment focus
  • Exhibit 50: Danaher - Key offerings
  • Exhibit 51: GE Healthcare - Vendor overview
  • Exhibit 52: GE Healthcare - Business segments
  • Exhibit 53: GE Healthcare - Organizational developments
  • Exhibit 54: GE Healthcare - Geographic focus
  • Exhibit 55: GE Healthcare - Segment focus
  • Exhibit 56: GE Healthcare - Key offerings
  • Exhibit 57: Merck KGaA - Vendor overview
  • Exhibit 58: Merck KGaA - Business segments
  • Exhibit 59: Merck KGaA - Organizational developments
  • Exhibit 60: Merck KGaA - Geographic focus
  • Exhibit 61: Merck KGaA - Segment focus
  • Exhibit 62: Merck KGaA - Key offerings
  • Exhibit 63: Sartorius - Vendor overview
  • Exhibit 64: Sartorius - Business segments
  • Exhibit 65: Sartorius - Organizational developments
  • Exhibit 66: Sartorius - Geographic focus
  • Exhibit 67: Sartorius - Segment focus
  • Exhibit 68: Sartorius - Key offerings
  • Exhibit 69: Thermo Fisher Scientific - Vendor overview
  • Exhibit 70: Thermo Fisher Scientific - Business segments
  • Exhibit 71: Thermo Fisher Scientific - Organizational developments
  • Exhibit 72: Thermo Fisher Scientific - Geographic focus
  • Exhibit 73: Thermo Fisher Scientific - Segment focus
  • Exhibit 74: Thermo Fisher Scientific - Key offerings
Back to Top